LPL Financial LLC Has $4.17 Million Stake in abrdn Life Sciences Investors $HQL

Key Points

• LPL Financial LLC increased its holdings in abrdn Life Sciences Investors by 14.4% during the first quarter, now owning approximately 1.14% of the company valued at $4.17 million.
• Other institutional investors, including Flagship Harbor Advisors LLC and Allspring Global Investments, have also significantly increased their stakes in abrdn Life Sciences Investors, with institutional ownership at 32.21%.
• The company announced a quarterly dividend of $0.42 per share, representing a 12.3% yield, to be paid on September 30th to investors on record as of August 22nd.

LPL Financial LLC grew its holdings in shares of abrdn Life Sciences Investors (NYSE:HQL - Free Report) by 14.4% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 328,402 shares of the company's stock after acquiring an additional 41,307 shares during the quarter. LPL Financial LLC owned 1.14% of abrdn Life Sciences Investors worth $4,167,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in HQL. Wealthcare Advisory Partners LLC acquired a new position in abrdn Life Sciences Investors during the 1st quarter worth approximately $131,000. Cambridge Investment Research Advisors Inc. bought a new stake in shares of abrdn Life Sciences Investors during the first quarter worth $134,000. Wedbush Securities Inc. acquired a new position in shares of abrdn Life Sciences Investors during the first quarter worth $149,000. Stratos Wealth Partners LTD. lifted its stake in shares of abrdn Life Sciences Investors by 7.4% in the 1st quarter. Stratos Wealth Partners LTD. now owns 14,176 shares of the company's stock valued at $180,000 after acquiring an additional 971 shares during the last quarter. Finally, Guggenheim Capital LLC acquired a new stake in shares of abrdn Life Sciences Investors during the 4th quarter valued at $211,000. Institutional investors own 32.21% of the company's stock.

abrdn Life Sciences Investors Price Performance

HQL traded up $0.03 on Tuesday, reaching $14.01. The stock had a trading volume of 27,629 shares, compared to its average volume of 120,589. abrdn Life Sciences Investors has a fifty-two week low of $10.55 and a fifty-two week high of $15.90. The firm has a 50-day moving average of $13.10 and a 200-day moving average of $12.86.

abrdn Life Sciences Investors Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Friday, August 22nd will be issued a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 12.0%. The ex-dividend date is Friday, August 22nd.

About abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.